Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Peterson AC, Harlin H, Karrison T, Vogelzang NJ, Knost JA, Kugler JW, Lester E, Vokes E, Gajewski TF, Stadler WM; University of Chicago Phase II Consortium. Peterson AC, et al. Among authors: harlin h. Invest New Drugs. 2006 Mar;24(2):141-9. doi: 10.1007/s10637-006-5935-4. Invest New Drugs. 2006. PMID: 16514482 Clinical Trial.
Immune suppression in the tumor microenvironment.
Gajewski TF, Meng Y, Harlin H. Gajewski TF, et al. Among authors: harlin h. J Immunother. 2006 May-Jun;29(3):233-40. doi: 10.1097/01.cji.0000199193.29048.56. J Immunother. 2006. PMID: 16699366 Review.
Immune resistance orchestrated by the tumor microenvironment.
Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. Gajewski TF, et al. Among authors: harlin h. Immunol Rev. 2006 Oct;213:131-45. doi: 10.1111/j.1600-065X.2006.00442.x. Immunol Rev. 2006. PMID: 16972901 Review.
50 results